0000899243-20-021148.txt : 20200804
0000899243-20-021148.hdr.sgml : 20200804
20200804162320
ACCESSION NUMBER: 0000899243-20-021148
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200731
FILED AS OF DATE: 20200804
DATE AS OF CHANGE: 20200804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHROFF ZUBEEN
CENTRAL INDEX KEY: 0001056630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36415
FILM NUMBER: 201073632
MAIL ADDRESS:
STREET 1: C/O HALSEY DRUG CO INC
STREET 2: 1827 PACIFIC STREET
CITY: BROOKLYN
STATE: NY
ZIP: 11233
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quotient Ltd
CENTRAL INDEX KEY: 0001596946
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 264719797
STATE OF INCORPORATION: Y9
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
BUSINESS PHONE: 41274832286
MAIL ADDRESS:
STREET 1: 28 ESPLANADE
CITY: SAINT HELIER
STATE: Y9
ZIP: JE2 3QA
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-31
0
0001596946
Quotient Ltd
QTNT
0001056630
SHROFF ZUBEEN
C/O GALEN PARTNERS,
680 WASHINGTON BLVD
STAMFORD
CT
06901
1
0
0
0
Ordinary Shares
7329074
I
See footnote
Ordinary Shares
2020-07-31
4
M
0
3856
A
54665
D
Ordinary Shares Option (Right to buy)
11.62
2025-10-31
Ordinary Shares
7505
7505
D
Ordinary Shares Option (Right to buy)
8.00
2024-04-29
Ordinary Shares
5000
5000
D
Ordinary Shares Option (Right to buy)
9.95
2024-10-31
Ordinary Shares
5025
5025
D
Ordinary Shares Option (Right to buy)
5.73
2026-10-31
Ordinary Shares
8726
8726
D
Ordinary Shares Option (Right to buy)
5.21
2027-10-31
Ordinary Shares
9597
9597
D
Ordinary Shares Option (Right to buy)
6.41
2028-10-31
Ordinary Shares
6240
6240
D
Restricted Stock Units
2020-07-31
4
M
0
3856
0.00
D
Ordinary Shares
3856
3856
D
Ordinary Shares Option (Right to buy)
7.78
2029-10-31
Ordinary Shares
8158
8158
D
Restricted Stock Units convert into ordinary shares on a one-for-one basis.
Includes 6,613,590 ordinary shares held of record by Galen V, 564,780 ordinary shares held by Galen International V, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Shroff is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V, Galen International V and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
All 7,505 options have vested and remain exercisable.
All 5,000 options have vested and remain exercisable
All 5,025 options have vested and remain exercisable.
All 8,726 options have vested and remain exercisable.
6,398 options have vested and remain exercisable, and 3,199 options will vest on October 31, 2020.
2,080 options vested on October 31, 2019 and remain exercisable, 2,080 options will vest on October 31, 2020 and 2,080 options will vest on October 31, 2021.
On October 31, 2019, the Reporting Person was granted 15,424 restricted stock units. Of the 15,424 restricted stock units, 11,568 restricted stock units have vested and have been exercised. The remaining 3,856 restricted stock units will vest on October 31, 2020.
The options vest and become exercisable in three equal annual installments beginning October 31, 2020.
/s/ Zubeen Shroff
2020-08-04